These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 28098165)
1. Combination of mometasone furoate and oxymetazoline for the treatment of adenoid hypertrophy concomitant with allergic rhinitis: A randomized controlled trial. Liu W; Zhou L; Zeng Q; Luo R Sci Rep; 2017 Jan; 7():40425. PubMed ID: 28098165 [TBL] [Abstract][Full Text] [Related]
2. [Clinical observation of mometasone furoate nasal spray combined with montelukast sodium in the treatment of adenoid hypertrophy in children]. Liu W; Chen RJ Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):366-368. PubMed ID: 29871263 [No Abstract] [Full Text] [Related]
3. Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis. Baroody FM; Brown D; Gavanescu L; DeTineo M; Naclerio RM J Allergy Clin Immunol; 2011 Apr; 127(4):927-34. PubMed ID: 21377716 [TBL] [Abstract][Full Text] [Related]
4. Mometasone furoate intranasal spray is effective in reducing symptoms and adenoid size in children and adolescents with adenoid hypertrophy. Ghafar MHA; Mohamed H; Mohammad NMY; Mohammad ZW; Madiadipoera T; Wang Y; Abdullah B Acta Otorrinolaringol Esp (Engl Ed); 2020; 71(3):147-153. PubMed ID: 31400807 [TBL] [Abstract][Full Text] [Related]
5. Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis. Meltzer EO; Bernstein DI; Prenner BM; Berger WE; Shekar T; Teper AA Am J Rhinol Allergy; 2013; 27(2):102-8. PubMed ID: 23562197 [TBL] [Abstract][Full Text] [Related]
6. Systematic review and meta-analysis of randomized controlled trials on the role of mometasone in adenoid hypertrophy in children. Chohan A; Lal A; Chohan K; Chakravarti A; Gomber S Int J Pediatr Otorhinolaryngol; 2015 Oct; 79(10):1599-608. PubMed ID: 26235732 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effects of montelukast, mometasone furoate, and combined therapyon adenoid size: a randomized, prospective, clinical trial with objective data. Tuhanıoğlu B; Erkan SO Turk J Med Sci; 2017 Dec; 47(6):1736-1743. PubMed ID: 29306232 [TBL] [Abstract][Full Text] [Related]
8. Does oxymetazoline increase the efficacy of nasal steroids in treating nasal polyposis? Kirtsreesakul V; Khanuengkitkong T; Ruttanaphol S Am J Rhinol Allergy; 2016 May; 30(3):195-200. PubMed ID: 27216350 [TBL] [Abstract][Full Text] [Related]
9. [The influence of medical treatment of the perennial allergic rhinitis on the adenoid size in children]. Modrzyński M; Zawisza E; Mazurek H Otolaryngol Pol; 2006; 60(4):543-50. PubMed ID: 17152807 [TBL] [Abstract][Full Text] [Related]
10. Montelukast combined with intranasal mometasone furoate versus intranasal mometasone furoate; a comparative study in treatment of adenoid hypertrophy. Ras AE; Hamed MH; Abdelalim AA Am J Otolaryngol; 2020; 41(6):102723. PubMed ID: 32950830 [TBL] [Abstract][Full Text] [Related]
11. The role of mometasone furoate aqueous nasal spray in the treatment of adenoidal hypertrophy in the pediatric age group: preliminary results of a prospective, randomized study. Berlucchi M; Salsi D; Valetti L; Parrinello G; Nicolai P Pediatrics; 2007 Jun; 119(6):e1392-7. PubMed ID: 17533178 [TBL] [Abstract][Full Text] [Related]
12. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. The 194-079 Study Group. Mandl M; Nolop K; Lutsky BN Ann Allergy Asthma Immunol; 1997 Sep; 79(3):237-45. PubMed ID: 9305231 [TBL] [Abstract][Full Text] [Related]
13. Mometasone Furoate Use for Recurrent Adenoid Hypertrophy: Randomized Controlled Clinical Trial. Roushdy MM; Jalil AAA; Saeed AM Indian J Otolaryngol Head Neck Surg; 2023 Sep; 75(3):1639-1646. PubMed ID: 37636767 [TBL] [Abstract][Full Text] [Related]
14. The role of mometasone furoate nasal spray in the treatment of adenoidal hypertrophy in the adolescents: a prospective, randomized, cross-over study. Yilmaz HB; Celebi S; Sahin-Yilmaz A; Oysu C Eur Arch Otorhinolaryngol; 2013 Sep; 270(10):2657-61. PubMed ID: 23381494 [TBL] [Abstract][Full Text] [Related]
15. Exploring the characteristics of children with obstructive adenoid responding to mometasone fuorate monohydrate: preliminary results. Bitar MA; Mahfoud L; Nassar J; Dana R Eur Arch Otorhinolaryngol; 2013 Mar; 270(3):931-7. PubMed ID: 23010795 [TBL] [Abstract][Full Text] [Related]
16. Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep. Meltzer EO; Munafo DA; Chung W; Gopalan G; Varghese ST Ann Allergy Asthma Immunol; 2010 Jul; 105(1):65-74. PubMed ID: 20642206 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the intranasal steroid treatment outcomes in adenoid tissue hypertrophy with or without allergic rhinitis. Arslan E; Tulaci KG; Canakci H; Arslan S; Yazici H Am J Otolaryngol; 2021; 42(4):102983. PubMed ID: 33610082 [TBL] [Abstract][Full Text] [Related]
18. A study of the effect of nasal steroid sprays in perennial allergic rhinitis patients with rhinitis medicamentosa. Ferguson BJ; Paramaesvaran S; Rubinstein E Otolaryngol Head Neck Surg; 2001 Sep; 125(3):253-60. PubMed ID: 11555762 [TBL] [Abstract][Full Text] [Related]
19. [Effect of nasal glucocorticoid combined with loratadine or montelukast on allergic rhinitis]. Jia MH; Chen XY; Zhang Y; Liao ZS Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):369-373. PubMed ID: 29871264 [No Abstract] [Full Text] [Related]
20. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials. Penagos M; Compalati E; Tarantini F; Baena-Cagnani CE; Passalacqua G; Canonica GW Allergy; 2008 Oct; 63(10):1280-91. PubMed ID: 18721246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]